Utah Medical Products (FRA:UTM) Current Ratio: 48.61 (As of Jun. 2026) — 209% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:UTM Utah Medical Products Inc FRA:UTM
73 GF Score
Price €58.50
GF Value €49.20
! 8 Warning Signs
View Full Analysis

What is Utah Medical Products Current Ratio?

Utah Medical Products FRA:UTM -2.50% 73 Current Ratio is 48.61 as of Jun. 2026, which is 209% above its 10-year median of 15.73. GuruFocus rates FRA:UTM with a GF Score™ of 73/100 and a GF Value™ of €49.20. The stock has 8 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Utah Medical Products ranks better than 99.06% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Utah Medical Products's current ratio for the quarter that ended in Jun. 2026 was 48.61.

Utah Medical Products has a current ratio of 48.61. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Utah Medical Products's Current Ratio or its related term are showing as below:

FRA:UTM' s Current Ratio Range Over the Past 10 Years
Min: 6.48   Med: 15.73   Max: 48.62
Current: 48.62

During the past 13 years, Utah Medical Products's highest Current Ratio was 48.62. The lowest was 6.48. And the median was 15.73.

FRA:UTM's Current Ratio is ranked better than
99.06% of 852 companies
in the Medical Devices & Instruments industry
Industry Median: 2.435 vs FRA:UTM: 48.62

Utah Medical Products  (FRA:UTM) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Utah Medical Products Current Ratio Related Terms


Utah Medical Products Current Ratio Historical Data

* Premium members only.

The historical data trend for Utah Medical Products's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Utah Medical Products Current Ratio Chart

Utah Medical Products Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.54 15.09 22.56 25.64 37.62

Utah Medical Products Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.87 32.06 37.62 28.64 48.61

FRA:UTM vs EMBC, SMTI, PDEX: Current Ratio Comparison

For the Medical Instruments & Supplies subindustry, Utah Medical Products's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Utah Medical Products Current Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's Current Ratio distribution charts can be found below:

* The bar in red indicates where Utah Medical Products's Current Ratio falls into.


FRA:UTM
73GF Score
Utah Medical Products Inc FRA:UTM
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Utah Medical Products Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Utah Medical Products's Current Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Current Ratio (A: Dec. 2025 )=Total Current Assets (A: Dec. 2025 )/Total Current Liabilities (A: Dec. 2025 )
=83.472/2.219
=37.62

Utah Medical Products's Current Ratio for the quarter that ended in Jun. 2026 is calculated as

Current Ratio (Q: Jun. 2026 )=Total Current Assets (Q: Jun. 2026 )/Total Current Liabilities (Q: Jun. 2026 )
=87.355/1.797
=48.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 48.61 mean?
Utah Medical Products (FRA:UTM) has a Current Ratio of 48.61 as of Jun. 2026. This is 209% above median its historical median of 15.73. Over the past decade, Utah Medical Products' Current Ratio has ranged from 6.48 to 48.62. According to the industry distribution chart, Utah Medical Products ranks #8 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 0.90000000000001%.
Is Utah Medical Products' Current Ratio too high?
Utah Medical Products' current Current Ratio of 48.61 is 209% above median its 10-year median of 15.73. Over the past 10 years, this metric has ranged from a low of 6.48 to a high of 48.62. The Medical Devices & Instruments industry median Current Ratio is 2.44. Utah Medical Products' value of 48.61 is 1896.3% above this industry median. Based on the distribution chart, Utah Medical Products ranks #8 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Utah Medical Products has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Utah Medical Products' Current Ratio compare to EMBC and SMTI?
According to the Medical Devices & Instruments industry distribution chart, Utah Medical Products ranks #8 out of 852 companies for Current Ratio. This places Utah Medical Products in the top 1% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.44. Utah Medical Products' value of 48.61 is 1896.3% above this benchmark. Historically, Utah Medical Products' own Current Ratio has ranged from 6.48 to 48.62 over the past decade. While the company's 10-year median is 15.73 vs. the industry median of 2.44, Utah Medical Products has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.44, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Utah Medical Products's current Current Ratio of 48.61 is 1896.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Utah Medical Products's current Current Ratio is 48.61, which is 209% above median its own 10-year median of 15.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Utah Medical Products stock overvalued right now?
Utah Medical Products (FRA:UTM) has a current Current Ratio of 48.61. The stock's GF Value™ is €49.20, compared to a current price of €58.50 — trading 18.9% above its estimated fair value. The current Current Ratio is 48.61, which is 209% above median its 10-year median of 15.73 and 1896.3% above the Medical Devices & Instruments industry median of 2.44. Utah Medical Products' overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Utah Medical Products (FRA:UTM), the current Current Ratio is 48.61 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Utah Medical Products (FRA:UTM) Overvalued in 2026?

Based on GuruFocus' analysis, Utah Medical Products stock appears to be overvalued. The current stock price of €58.50 is trading 18.9% above its estimated GF Value™ of €49.20.

Key valuation signals for FRA:UTM:

  • Current Ratio: 48.61 (209% above median its 10-year median of 15.73)
  • GF Value™: €49.20 vs. price of €58.50 (18.9% above fair value)
  • GF Score™: 73/100 with 8 warning signs
  • Industry Position: 1896.3% above the Medical Devices & Instruments median (#8 of 852)

No single metric tells the full story. See the FRA:UTM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Utah Medical Products Business Description

Other Exchanges UTMD:USA
Address 7043 South 300 West, Midvale, UT, USA, 84047
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
73GF Score

Get the complete analysis for FRA:UTM

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€58.50
Price
€49.20
GF Value